SCHEMBL98895

SCHEMBL98895

NCc1ccc(-c2ccccc2)c([N+](=O)[O-])c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
TDP1 Q9NUW8 1/20 0.56
CSNK2A1 P68400 2/20 0.54
PTGES O14684 1/20 0.45
LOXL2 Q9Y4K0 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
MAPT P10636 2/20 0.41
RAB9A P51151 2/20 0.40
POLB P06746 1/20 0.40
NPC1 O15118 1/20 0.40
HPGD P15428 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
CYP19A1 P11511 1/20 0.40
RCE1 Q9Y256 1/20 0.39
HPRT1 P00492 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL101169 0.88 ALDH1A1 (0.53) ALDH1A1TDP1CSNK2A1PTGESLOXL2
SCHEMBL3905288 0.85 ALDH1A1 (0.58) ALDH1A1TDP1PTGESCRHBPCRHR2
SCHEMBL3904427 0.84 ALDH1A1 (0.56) ALDH1A1TDP1CSNK2A1PTGESCRHBP
SCHEMBL15860172 0.84 ALDH1A1 (0.56) ALDH1A1TDP1PTGESCRHBPCRHR2
SCHEMBL9590489 0.84 ALDH1A1 (0.56) ALDH1A1TDP1PTGESCRHBPCRHR2
SCHEMBL279052 0.84 ALDH1A1 (0.56) ALDH1A1TDP1PTGESCRHBPCRHR2
SCHEMBL98747 0.81 TDP1 (0.53) ALDH1A1TDP1PTGESCRHBPCRHR2
SCHEMBL15822786 0.81 ALDH1A1 (0.53) ALDH1A1TDP1PTGESCRHBPCRHR2
SCHEMBL8701556 0.80 ALDH1A1 (0.65) ALDH1A1TDP1LOXL2TAAR1TSHR
SCHEMBL27559990 0.79 FFAR1 (0.53) ALDH1A1TDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9072734-B2 Quaternary ammonium salt compounds TEIJIN PHARMA LIMITED (JP) 2015-07-07 US disclosed
EP-2426121-A1 QUATERNARY AMMONIUM SALT COMPOUND Teijin Pharma Limited (JP) 2012-03-07 EP disclosed
US-20120046467-A1 QUATERNARY AMMONIUM SALT COMPOUNDS TEIJIN PHARMA LIMITED (JP) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046467-A1 QUATERNARY AMMONIUM SALT COMPOUNDS ADRB2, AGTR2, ADRB3 ALDH1A1 1896/4885TDP1 4429/4885CSNK2A1 337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.